Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for treating cancers which present antigen FB5 with humanized antibodies

Method for treating cancers which present antigen FB5 with humanized antibodies

US Patent 6391302 · Granted May 21, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody specific for CD22 and methods of use thereof2024
Anti-kit antibodies and uses thereof2024
Anti-MET antibodies and methods of use thereof2024
Humanized antibodies against CEACAM12024
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking2023
Compositions and methods for immunotherapy2023
Antibodies, uses thereof and conjugates thereof2022
Polynucleotides encoding humanized antibodies against CEACAM12022
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor2022
Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and strok2022
Methods of treating by administering anti-kit antibodies2020
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking2020